当前位置:首页 >财报库 > 报告详情

晖致Viatris(VTRS)2025年第一季度财报「NASDAQ」(英文版)(71页).pdf

上传人: Kell****reet 编号:653861 2025-05-20 71页 805.59KB

下载:

1、UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington,D.C.20549Form 10-QQUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF1934For the quarterly period ended March 31,2025ORTRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF1934For th

2、e transition period from _to_ Commission file number 001-39695VIATRIS INC.(Exact name of registrant as specified in its charter)Delaware83-4364296(State or other jurisdiction of incorporation or organization)(I.R.S.Employer Identification No.)1000 Mylan Boulevard,Canonsburg,Pennsylvania 15317(Addres

3、s of principal executive offices)(724)514-1800(Registrants telephone number,including area code)Securities registered pursuant to Section 12(b)of the Act:Title of Each Class:Trading Symbol(s)Name of Each Exchange on Which Registered:Common Stock,par value$0.01 per shareVTRSThe NASDAQ Stock MarketInd

4、icate by check mark whether the registrant(1)has filed all reports required to be filed by Section 13 or 15(d)of the Securities Exchange Act of1934 during the preceding 12 months(or for such shorter period that the registrant was required to file such reports),and(2)has been subject to such filingre

5、quirements for the past 90 days.Yes No Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405of Regulation S-T(232.405 of this chapter)during the preceding 12 months(or for such shorter period that the regi

6、strant was required to submit suchfiles).Yes No Indicate by check mark whether the registrant is a large accelerated filer,an accelerated filer,a non-accelerated filer,a smaller reporting company,oran emerging growth company.See the definitions of“large accelerated filer,”“accelerated filer,”“smalle

word格式文档无特别注明外均可编辑修改,预览文件经过压缩,下载原文更清晰!
三个皮匠报告文库所有资源均是客户上传分享,仅供网友学习交流,未经上传用户书面授权,请勿作商用。
本文是Viatris公司2025年第一季度10-Q报告的摘录,主要内容包括: 1. 公司简介:Viatris是一家全球性的制药公司,由Mylan和Pfizer的Upjohn业务合并而成。 2. 财务数据:2025年第一季度,公司净销售额为32.43亿美元,较2024年同期的36.54亿美元有所下降。净亏损为30.42亿美元,而2024年同期为盈利1.14亿美元。 3. 资产负债表:截至2025年3月31日,公司总资产为384.75亿美元,总负债为228.25亿美元,股东权益为156.50亿美元。 4. 业务概述:报告期内,公司完成了对Idorsia的资产收购,并继续推进其业务重组和剥离计划。 5. 风险因素:公司面临包括药品定价压力、监管环境变化、贸易政策不确定性等在内的多项风险。 6. 未来展望:公司将继续优化其业务组合,并寻求新的增长机会。
2025年第一季度Viatris公司财务状况如何? Viatris公司如何管理外汇风险和利率风险? Viatris公司2025年第一季度哪些产品销售表现良好?
客服
商务合作
小程序
服务号
折叠